Authors:
Dreau, D
Foster, M
Hogg, M
Swiggett, J
Holder, WD
White, RL
Citation: D. Dreau et al., Angiogenic and immune parameters during recombinant interferon-alpha 2b adjuvant treatment in patients with melanoma, ONCOL RES, 12(5), 2000, pp. 241-251
Authors:
Burg, KJL
Holder, WD
Culberson, CR
Beiler, RJ
Greene, KG
Loebsack, AB
Roland, WD
Eiselt, P
Mooney, DJ
Halberstadt, CR
Citation: Kjl. Burg et al., Comparative study of seeding methods for three-dimensional polymeric scaffolds (vol 51, pg 642, 2000), J BIOMED MR, 52(3), 2000, pp. 576-576
Authors:
Holder, WD
Bland, KI
Copeland, EM
Iglehart, JD
Citation: Wd. Holder et al., Testing for hereditary breast and ovarian cancer in the southeastern United States - Discussion, ANN SURG, 231(5), 2000, pp. 632-634
Authors:
Dreau, D
Culberson, C
Wyatt, S
Holder, WD
Citation: D. Dreau et al., Human papilloma virus in melanoma biopsy specimens and its relation to melanoma progression, ANN SURG, 231(5), 2000, pp. 664-670
Citation: Jp. O'Leary et al., Human papilloma virus in melanoma biopsy specimens and its relation to melanoma progression - Discussion, ANN SURG, 231(5), 2000, pp. 670-671
Authors:
Dreau, D
Bosserhoff, AK
White, RL
Buettner, R
Holder, WD
Citation: D. Dreau et al., Melanoma-inhibitory activity protein concentrations in the blood of melanoma patients treated with immunotherapy, ONCOL RES, 11(1), 1999, pp. 55-61